Polar Asset Management Partners Inc. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Polar Asset Management Partners Inc. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$3,365,700
-15.1%
2,500,0000.0%0.05%
+4.1%
Q4 2022$3,962,345
-60.1%
2,500,000
-66.7%
0.05%
-52.0%
Q2 2021$9,942,000
-26.5%
7,500,000
-25.0%
0.10%
-23.3%
Q1 2021$13,523,00010,000,0000.13%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,497,0001.31%
SHENKMAN CAPITAL MANAGEMENT INC 4,366,000$5,924,0000.54%
Aequim Alternative Investments LP 7,609,000$10,088,0000.43%
MACKAY SHIELDS LLC 27,806,000$37,405,0000.35%
Weiss Asset Management LP 10,000,000$13,290,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,541,0000.13%
Polar Asset Management Partners Inc. 7,500,000$9,942,0000.10%
LORD, ABBETT & CO. LLC 22,141,000$29,732,0000.07%
Calamos Advisors LLC 7,500,000$9,967,0000.05%
D. E. Shaw & Co., Inc. 39,270,000$52,046,0000.04%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders